Spotlight on Science Meetings, Conferences and Events brings you information on the following: New York Pharma Forum's 28th General Assembly - Pharma's Commitment to Global Health to be held on 12/01/17, 3:00-5:30 PM.
This symposium will focus on exploring a new global health ecosystem model, where innovation, strategic funding and alliances accelerate development of new medicines and global access. The panelists will discuss effective mechanisms for providing value to underserved communities while creating growth and meeting business goals.
Mr. Darren Back, Senior Director, Social Investments & Global Health Programs,
Pfizer Inc. and Pfizer Foundation
Mr. Michael Nally, President, Global Vaccines, MSD
Dr. Andrin Oswald, Director of Life Sciences Partnerships,
The Bill & Melinda Gates Foundation
Dr. BT Slingsby, CEO & Executive Director,
Global Health Innovative Technology (GHIT) Fund
Panel Facilitator: Dr. Jeffrey L. Sturchio, President & CEO, Rabin Martin
New York Pharma Forum Inc. (NYPF), is a non-profit organization of international biopharmaceutical companies that has a special focus on the Japanese pharmaceutical industry and market. The organization encourages dialogue among U.S., Japanese and other international biopharmaceutical executives and business professionals on global issues shaping the biopharmaceutical industry and healthcare landscape. For more information about NYPF, visit: http://www.nypharmaforum.org/.
Cost: This event is free of charge for healthcare and biopharmaceutical industry professionals and journalists
The New York Academy of Medicine (Room 20, 2nd Floor)
1216 5th Ave, New York, NY 10029 (212) 822-7200
Friday, December 1, 2017 from 3:00-5:30 PM